Evotec has established a position by assembling scientific experts and integrating technologies as well as experience and expertise in therapeutic areas including neuroscience, pain, metabolic diseases as well
The FDA has warned the company for not adhering current good manufacturing practice (cGMP) for finished pharmaceuticals. The FDA has found deviations related to sampling and testing of
Currently, Nyloxin is available as an oral spray to treat back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint
The MAA entitled, ‘TESAMORELIN FERRER,’ was filed on the basis of positive results from two Phase 3 clinical trials. If approved, tesamorelin will receive marketing authorization for the
A research conducted by LifeCycle Pharma demonstrated that certain types of intravenous chemotherapy can be modified, utilizing LifeCycle Pharma technologies, to pill-based therapy. Herlev Hospital Oncology Department chief
Irosustat is an orally available irreversible steroid sulfatase (STS) inhibitor. According to futility analysis, the trial will not meet the primary endpoint and the superiority will not be
The modified complaint includes new claims alleging breach of contract, breach of the implied covenant of good faith and fair dealing, tortious interference with contractual relationships, and civil
Viorra is a non-invasive topical treatment to assist women who are suffering from a range of female sexual arousal disorders (FSAD) that cause a lack of vaginal lubricity
Avastin is a prescription-only medicine that is a solution for intravenous infusion. In the trial, the women who received Avastin showed 52% reduction in the risk of their
Before joining Asmacure, Driscoll served as the CEO and director of Javelin Pharmaceuticals, a developer of acute care pain products. Prior to Javelin, Driscoll held senior positions in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.